Document:

Exhibit 10.1

FIFTH AMENDMENT TO
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT

This Fifth Amendment to Amended and Restated Loan and
Security Agreement (this “Amendment”) is entered into as of January 23, 2007,
by and between COMERICA BANK (“Bank”) and WJ COMMUNICATIONS, INC. (“Borrower”).

RECITALS

Borrower and Bank are parties to that certain Amended
and Restated Loan and Security Agreement dated as of September 23, 2003,
as amended from time to time including by that certain First Amendment to
Amended and Restated Loan and Security Agreement dated as of June 13, 2005,
that certain Second Amendment to Amended and Restated Loan and Security
Agreement dated as of July 12, 2005, that certain Third Amendment to Amended
and Restated Loan and Security Agreement dated as of September 28, 2005,
that certain Fourth Amendment to Amended and Restated Loan and Security
Agreement dated as of December 27, 2005 and that certain bi-lateral
extension letter dated as of December 31, 2006 (the “Agreement”). The
parties desire to amend the Agreement in accordance with the terms of this
Amendment.

NOW, THEREFORE,
the parties agree as follows:

1.             The
following defined terms in Section 1.1 of the Agreement hereby are added,
amended or restated as follows:

“Consolidated Net Income
(or Deficit)” means the consolidated net income (or deficit) of any Person and
its Subsidiaries, after deduction of all expenses, taxes, and other proper
charges, determined in accordance with GAAP, after eliminating therefrom all
extraordinary nonrecurring items of income.

“Consolidated Total
Interest Expense” means with respect to any Person for any period, the
aggregate amount of interest required to be paid or accrued by a Person and its
Subsidiaries during such period on all Indebtedness of such Person and its
Subsidiaries outstanding during all or any part of such period, whether such
interest was or is required to be reflected as an item of expense or
capitalized, including payments consisting of interest in respect of any
capitalized lease or any synthetic lease, and including commitment fees, agency
fees, facility fees, balance deficiency fees and similar fees or expenses in
connection with the borrowing of money.

“EBITDA” means with
respect to any fiscal period an amount equal to the sum of (a) Consolidated
Net Income of the Borrower and its Subsidiaries for such fiscal period, plus
(b) in each case to the extent deducted in the calculation of the Borrower’s
Consolidated Net Income and without duplication, (i) depreciation and
amortization for such period, plus (ii) income tax expense for such
period, plus (iii) Consolidated Total Interest Expense paid or accrued
during such period, plus (iv) non-cash expense associated with granting
stock options, and minus, to the extent added in computing Consolidated Net
Income, and without duplication, all extraordinary and non-recurring revenue
and gains (including income tax benefits) for such period, all as determined in
accordance with GAAP

“Revolving
Maturity Date” means June 30, 2008.

2.             Section
2.1.1(c) of the Agreement is hereby amended and restated in its entirety to
read as follows:

“Prime Rate Advances. 
Each Prime Rate Advance shall be in an amount of not less than Five
Hundred Thousand Dollars ($500,000). The outstanding principal balance of each
Prime Rate Advance shall bear interest until principal is due (computed daily
on the basis of a 360 day year and actual days elapsed), at a floating rate per
annum equal to one quarter of one percent (0.25%) below the Prime Rate. Borrower
shall pay the entire outstanding principal amount of each Prime Rate Advance on
the Revolving Maturity Date.”

3.             Section
6.3(d) of the Agreement is hereby amended and restated in its entirety to read
as follows:

 

(d) within
ninety (90) days after the end of Borrower’s fiscal year, a report signed by
Borrower, in form reasonably acceptable to Bank, listing any applications or
registrations that Borrower has made or filed in respect of any material
Patents, Copyrights or Trademarks and the status of any outstanding applications
or registrations, as well as any material change in Borrower’s intellectual
property, including but not limited to any subsequent ownership right of
Borrower in or to any material Trademark, Patent or Copyright not specified in Exhibits A,
B, and C of the Intellectual Property Security Agreement
delivered to Bank by Borrower in connection with this Agreement

4.             Section
6.7 of the Agreement is hereby amended and restated in its entirety to read as
follows:

“Tangible Net Worth.  Borrower
shall maintain a Tangible Net Worth of Not Less than Twelve Million Dollars
($12,000,000) plus an amount equal to fifty percent (50%) of Borrower’s net
income for each fiscal quarter, calculated in accordance with GAAP, plus an
amount equal to seventy-five percent (75%) of the proceeds received after December 22,
2005 from the sale or issuance by Borrower of its equity securities or
Subordinated Debt.”

5.             Section 6.8 of the Agreement is hereby amended and
restated in its entirety to read as follows:

“Domestic Cash Balance. 
At all times prior to Borrower achieving two consecutive quarters of
positive EBITDA, the aggregate balance of Borrower’s unrestricted cash and cash
equivalents located in the United States minus the aggregate balance of
all Indebtedness (including without limitation any issued and drawn Letters of
Credit and other Contingent Obligations) owing from Borrower to Bank, shall be
at least Twelve Million Dollars ($12,000,000) at all times.”

6.             Exhibit
C to the Agreement is hereby replaced with Exhibit C attached hereto.

7.             Bank
hereby waives Borrower’s failure to deliver its quarterly compliance
certificate in accordance with Section 6.3 of the Agreement for the fiscal
quarter ending September 30, 2006.

8.             No
course of dealing on the part of Bank or its officers, nor any failure or delay
in the exercise of any right by Bank, shall operate as a waiver thereof, and
any single or partial exercise of any such right shall not preclude any later
exercise of any such right. Bank’s failure at any time to require strict performance
by Borrower of any provision shall not affect any right of Bank thereafter to
demand strict compliance and performance. Any suspension or waiver of a right
must be in writing signed by an officer of Bank.

9.             Unless
otherwise defined, all initially capitalized terms in this Amendment shall be
as defined in the Agreement. The Agreement, as amended hereby, shall be and
remain in full force and effect in accordance with its respective terms and
hereby is ratified and confirmed in all respects. Except as expressly set forth
herein, the execution, delivery, and performance of this Amendment shall not
operate as a waiver of, or as an amendment of, any right, power, or remedy of
Bank under the Agreement, as in effect prior to the date hereof.

10.           Borrower
represents and warrants that the Representations and Warranties contained in
the Agreement are true and correct as of the date of this Amendment, and that
no Event of Default has occurred and is continuing.

11.           As
a condition to the effectiveness of this Amendment, Bank shall have received,
in form and substance satisfactory to Bank, the following:

(a)           this Amendment, duly executed by
Borrower;

(b)           a Certificate of the Secretary of
Borrower with respect to incumbency and resolutions authorizing the execution
and delivery of this Amendment;

(c)           all reasonable Bank Expenses incurred
through the date of this Amendment, which may be debited from any of Borrower’s
accounts; and

(d)           such other documents, and completion
of such other matters, as Bank may reasonably deem necessary or appropriate.

12.           This
Amendment may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one instrument.

 

IN WITNESS
WHEREOF, the undersigned have executed this Amendment as of the first date
above written.

	
  

  	
  WJ COMMUNICATIONS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By: /s/ R. Gregory Miller

  
	
   

  	
   

  
	
   

  	
  Title: Chief Financial Officer

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  COMERICA BANK

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By: /s/ Guy Simpson

  
	
   

  	
   

  
	
   

  	
  Title: Vice PresidentExhibit 10.2

[COMERICA
LETTERHEAD]

January 25, 2007

Greg Miller

CFO

WJ Communications, Inc.

401 River Oaks Parkway

San Jose, CA 95134

408.577.6261

Dear Greg:

Pursuant to our bilateral extension letter dated
12/27/06 (executed 12/31/06), WJ Communications’ Line of Credit was extended
until 1/21/07. Starting on 1/22/07, WJ Communications has an additional 30-day
Grace Period until the credit facility will automatically expire. During this
Grace Period, the credit facility will remain in full force without lapse or
termination, but WJ Communications will not be able to draw underneath the Commercial
Line of Credit during this period.

Please do not hesitate to contact me if you have any
questions. We appreciate WJ Communications business and look forward to completing
the 18-month extension we have discussed.

Sincerely,

/s/ Guy Simpson

Guy Simpson

Vice President

Technology & Life Sciences Banking Group

226 Airport Parkway

Suite 100

San Jose, CA 95110

408.451.5870Exhibit 10.1
  SECURITIES
PURCHASE AGREEMENT
  THIS SECURITIES PURCHASE
AGREEMENT (this “Agreement”)
is dated as of January 25, 2007, among CRDENTIA CORP., a Delaware corporation
(the “Company”),
and the investors identified on the signature pages hereto (each, an “Investor” and collectively,
the “Investors”).
  WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to
Section 4(2) of the Securities Act (as defined below) and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Investor, and each
Investor, severally and not jointly, desires to purchase from the Company
certain securities of the Company, as more fully described in this Agreement.
  NOW, THEREFORE, IN CONSIDERATION of
the mutual covenants contained in this Agreement, and for other good and
valuable consideration the receipt and adequacy of which are hereby
acknowledged, the Company and the Investors agree as follows:
  ARTICLE I.
  DEFINITIONS
  Section 1.1             Definitions.  In addition to the terms defined elsewhere in
this Agreement, for all purposes of this Agreement, the following terms shall
have the meanings indicated in this Section 1.1:
  “Action” means any action, suit, inquiry,
notice of violation, proceeding (including any partial proceeding such as a
deposition) or investigation pending or threatened in writing against or
affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency,
regulatory authority (federal, state, county, local or foreign), stock market,
stock exchange or trading facility.
  “Affiliate” means any Person that, directly
or indirectly through one or more intermediaries, controls or is controlled by
or is under common control with a Person, as such terms are used in and
construed under Rule 144.
  “Business Day” means any day except
Saturday, Sunday and any day which is a federal legal holiday or a day on which
banking institutions in the State of New York are authorized or required by law
or other governmental action to close.
  “Closing” means the closing of the purchase
and sale of the Securities pursuant to Article II.
  “Closing Date” means the Business Day on
which all of the conditions set forth in Sections 5.1 and 5.2 hereof are
satisfied, or such other date as the parties may agree.
  “Commission” means the Securities and
Exchange Commission.

   
 

    “Common Stock” means the common stock of
the Company, par value $0.001 per share, and any securities into which such
common stock may hereafter be reclassified.
  “Common Stock Equivalents” means any
securities of the Company or any Subsidiary which entitle the holder thereof to
acquire Common Stock at any time, including without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that is at any
time convertible into or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock or other securities that entitle the holder to
receive, directly or indirectly, Common Stock.
  “Company Counsel” means Morrison &
Foerster LLP.
  “Company Deliverables” has the meaning set
forth in Section 2.2(a).
  “Disclosure Materials” has the meaning set
forth in Section 3.1(h).
  “Effective Date” means the date that the
Registration Statement required by Section 2(a) of the Registration Rights
Agreement is first declared effective by the Commission.
  “Exchange Act” means the Securities
Exchange Act of 1934, as amended.
  “GAAP” means U.S. generally accepted
accounting principles.
  “Intellectual Property Rights” has the
meaning set forth in Section 3.1(n).
  “Investment Amount” means, with respect to
each Investor, the Investment Amount indicated on such Investor’s signature
page to this Agreement.
  “Investor Deliverables” has the meaning set
forth in Section 2.2(b).
  “Investor Party” has the meaning set forth
in Section 4.7.
  “Lien” means any lien, charge, encumbrance,
security interest, right of first refusal or other restrictions of any kind.
  “Material Adverse Effect” means any of (i)
a material and adverse effect on the legality, validity or enforceability of
any Transaction Document, (ii) a material and adverse effect on the results of
operations, assets, business or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) an adverse impairment
to the Company’s ability to perform on a timely basis its obligations under any
Transaction Document.
  “New York Courts” means the state and
federal courts sitting in the City of New York, Borough of Manhattan.
  “Outside Date” means February 24, 2007.
  “Per Share Purchase Price” equals $0.60.

 2
 

    “Person” means an individual or
corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or
an agency or subdivision thereof) or other entity of any kind.
  “Proceeding” means an action, claim, suit,
investigation or proceeding (including, without limitation, an investigation or
partial proceeding, such as a deposition), whether commenced or threatened.
  “Registration Rights Agreement” means the
Registration Rights Agreement, dated as of the date of this Agreement, among
the Company and the Investors, in the form of Exhibit B hereto.
  “Registration Statement” means a
registration statement meeting the requirements set forth in the Registration
Rights Agreement and covering the resale by the Investors of the Shares.
  “Rule 144” means Rule 144 promulgated by
the Commission pursuant to the Securities Act, as such Rule may be amended from
time to time, or any similar rule or regulation hereafter adopted by the
Commission having substantially the same effect as such Rule.
  “SEC Reports” has the meaning set forth in
Section 3.1(h).
  “Securities” means the Shares.
  “Securities Act” means the Securities Act
of 1933, as amended.
  “Shares” means the shares of Common Stock
issued or issuable to the Investors pursuant to this Agreement.
  “Short Sales” include, without limitation,
all “short sales” as defined in Rule 200 promulgated under Regulation SHO under
the Exchange Act and all types of direct and indirect stock pledges, forward
sale contracts, options, puts, calls, swaps and similar arrangements (including
on a total return basis), and sales and other transactions through non-US
broker dealers or foreign regulated brokers.
  “Subsidiary” means any “significant
subsidiary” as defined in Rule 1-02(w) of the Regulation S-X promulgated by the
Commission under the Exchange Act.
  “Trading Day” means (i) a day on which the
Common Stock is traded on a Trading Market (other than the OTC Bulletin Board),
or (ii) if the Common Stock is not listed on a Trading Market (other than the
OTC Bulletin Board), a day on which the Common Stock is traded in the over-the-counter
market, as reported by the OTC Bulletin Board, or (iii) if the Common Stock is
not quoted on any Trading Market, a day on which the Common Stock is quoted in
the over-the-counter market as reported by the National Quotation
Bureau Incorporated (or any similar organization or agency succeeding to its
functions of reporting prices); provided, 

 3
 

    that in the event that the Common Stock is not listed
or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall
mean a Business Day.
  “Trading Market” means whichever of the New
York Stock Exchange, the American Stock Exchange, the NASDAQ Global Market, the
NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed
or quoted for trading on the date in question.
  “Transaction Documents” means this
Agreement and the Registration Rights Agreement and any other documents or
agreements executed in connection with the transactions contemplated hereunder.
  ARTICLE II.
  PURCHASE
AND SALE
  Section 2.1             Closing.  Subject to the terms and conditions set forth
in this Agreement, at each Closing the Company shall issue and sell to each
Investor, and each Investor shall, severally and not jointly, purchase from the
Company, the Shares representing such Investor’s Investment Amount.
  (a)           Initial Closing.  The initial purchase and sale of Shares shall
take place at the offices of Morrison & Foerster LLP, 12531 High Bluff
Drive, Suite 100, San Diego, California 92130 on January __, 2007, or at such
other time and place as the Company and the Investors pursuant hereto mutually
agree upon orally or in writing (which time and place are designated as the “Initial Closing”).
  (b)           Subsequent
Closings.  The Company may sell up to
the balance of the authorized number of Shares not sold as the Initial Closing
to such purchasers as it shall select provided that any such sale shall be
consummated not later than thirty (30) days after the Initial Closing. The
subsequent purchases and sales of the Shares shall take place at the offices of
Morrison & Foerster LLP, 12531 High Bluff Drive, Suite 100, San Diego,
California 92130, at such time or at such other place as the Company and the
Investors acquiring the Shares mutually agree upon orally or in writing (which
such time and place, together with the Initial Closing, are each designated as
a “Closing”)
  Section 2.2             Closing
Deliveries.  (a)  At the
Closing, the Company shall deliver or cause to be delivered to each Investor
the following (the “Company Deliverables”):
  (i)            a certificate
evidencing a number of Shares equal to such Investor’s Investment Amount
divided by the Per Share Purchase Price, registered in the name of such Investor;
  (ii)           a certificate of
the Transfer Agent with respect to the outstanding Common Stock number of the
Company as of the most recent practicable date;

 4
 

    (iii)          an Officer’s
Certificate and Secretary Certificate, in agreed form, duly executed by such officers
of the Company;
  (iv)          the Registration
Rights Agreement, duly executed by the Company.
  (b)           At the Closing, each
Investor shall deliver or cause to be delivered to the Company the following
(the “Investor Deliverables”):
  (i)            its Investment Amount, (A) in
United States dollars and in immediately available funds, by check or by wire
transfer to the following account designated for such purpose:
  Account Name: Crdentia Corp

Account Number: 1892275403,

Bank Name: Comerica Bank

ABA Routing Number: 121137522

Bank Address: 250 Lytton Avenue, 2nd Floor, Palo Alto, CA 94301
  or (B) by the cancellation of indebtedness; and
  (ii)           the Registration
Rights Agreement, duly executed by such Investor.
  ARTICLE III.
  REPRESENTATIONS
AND WARRANTIES
  Section 3.1             Representations
and Warranties of the Company.  The
Company hereby makes the following representations and warranties to each
Investor:
  (a)           Subsidiaries.  The Company has no direct or indirect
Subsidiaries other than as specified in the SEC Reports. The Company owns, directly
or indirectly, all of the capital stock of each Subsidiary free and clear of
any and all Liens, and all the issued and outstanding shares of capital stock
of each Subsidiary are validly issued and are fully paid, non-assessable and
free of preemptive and similar rights. Neither the Company nor any Subsidiary
is party to any material joint venture, nor has any ownership interest in any
entity that is material to the Company or as disclosed in the SEC Reports.
  (b)           Organization and
Qualification.  The Company and each
Subsidiary are duly incorporated or otherwise organized and validly existing
under the laws of the jurisdiction of its incorporation or organization (as
applicable), with the requisite power and authority to own and use its
properties and assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation of any of the material
provisions of its respective certificate or articles of incorporation, bylaws
or other organizational or charter documents. Except as set forth on Schedule
3.1(b), the Company and each Subsidiary are duly qualified to conduct its
respective businesses and are in good standing as a foreign corporation or
other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes 

 5
 

    such qualification necessary, except where the failure
to be so qualified or in good standing, as the case may be, could not,
individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect.
  (c)           Authorization;
Enforcement.  The Company has the
requisite corporate power and authority to enter into and to consummate the
transactions contemplated by each of the Transaction Documents and otherwise to
carry out its obligations thereunder. The execution and delivery of each of the
Transaction Documents by the Company and the consummation by it of the
transactions contemplated thereby have been duly authorized by all necessary
action on the part of the Company and no further action is required by the
Company in connection therewith. Each Transaction Document has been (or upon
delivery will have been) duly executed by the Company and, when delivered in
accordance with the terms hereof, will constitute the valid and binding
obligation of the Company enforceable against the Company in accordance with
its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws
relating to, or affecting generally the enforcement of, creditors’ rights and
remedies or by other equitable principles of general application.
  (d)           No Conflicts.  The execution, delivery and performance of
the Transaction Documents by the Company and the consummation by the Company of
the transactions contemplated thereby do not and will not (i) conflict with or
violate any provision of the Company’s or any Subsidiary’s certificate or
articles of incorporation, bylaws or other organizational or charter documents,
or (ii) conflict with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, or give to others any
rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or
other instrument (evidencing a Company or Subsidiary debt or otherwise) to
which the Company or any Subsidiary is a party or by which any property or
asset of the Company or any Subsidiary is bound, or (iii) result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other
restriction of any court or governmental authority to which the Company or a
Subsidiary is subject (including federal and state securities laws and
regulations), or by which any property or asset of the Company or a Subsidiary
is bound or affected; except in the case of each of clauses (ii) and (iii),
such as could not, individually or in the aggregate, have or reasonably be
expected to result in a Material Adverse Effect.
  (e)           Filings, Consents
and Approvals.  The Company is not
required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal,
state, local or other governmental authority or other Person in connection with
the execution, delivery and performance by the Company of the Transaction
Documents, other than (i) the filing with the Commission of one or more
Registration Statements in accordance with the requirements of the Registration
Rights Agreement, (ii) filings required by state securities laws, (iii) the
filing of a Notice of Sale of Securities on Form D with the Commission under
Regulation D of the Securities Act, (iv) the filings required in accordance
with Section 4.5, (v) such consents or waivers as may be required under
registration rights agreements entered into in connection with business
acquisitions 

 6
 

    effected prior to the date of this Agreement, and (vi)
the filing of any requisite notices with the Trading Market and (vii) those
that have been made or obtained prior to the date of this Agreement.
  (f)            Issuance of the
Securities.  The Securities have been
duly authorized and, when issued and paid for in accordance with the
Transaction Documents, will be duly and validly issued, fully paid and
nonassessable, free and clear of all Liens. The Company has reserved from its
duly authorized capital stock the Shares issuable pursuant to this Agreement.
  (g)           Capitalization.  The number of shares and type of all
authorized, issued and outstanding capital stock of the Company, and all shares
of Common Stock reserved for issuance under the Company’s various option and
incentive plans as of September 30, 2006, is accurately set forth in the SEC
Reports. Except as specified in the SEC Reports, no securities of the Company
are entitled to preemptive or similar rights. No Person has any right of first
refusal, preemptive right, right of participation, or any similar right to
participate in the transactions contemplated by the Transaction Documents. Except
as specified in the SEC Reports, and other than stock options granted pursuant
to the Company’s stock option plans following September 30, 2006, there are no
outstanding options, warrants, scrip rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exchangeable for, or giving any Person any
right to subscribe for or acquire, any shares of Common Stock, or contracts,
commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to issue additional shares of Common Stock,
or securities or rights convertible or exchangeable into shares of Common
Stock. The issue and sale of the Securities will not, immediately or with the
passage of time, obligate the Company to issue shares of Common Stock or other
securities to any Person (other than the Investors) and will not result in a
right of any holder of Company securities to adjust the exercise, conversion,
exchange or reset price under such securities.
  (h)           SEC Reports;
Financial Statements.  The Company
has filed all reports, forms and schedules required to be filed by it under the
Securities Act and the Exchange Act, including pursuant to Section 13(a) or
15(d) thereof, for the twelve months preceding the date hereof (or such shorter
period as the Company was required by law to file such reports) (the foregoing
materials being collectively referred to herein as the “SEC Reports”
and, together with the Schedules to this Agreement (if any), the “Disclosure Materials”)
on a timely basis or has timely filed a valid extension of such time of filing
and has filed any such SEC Reports prior to the expiration of any such
extension. The SEC Reports, as amended, when filed, complied in all material
respects with the requirements of the Securities Act and the Exchange Act and
the rules and regulations of the Commission promulgated thereunder, and none of
the SEC Reports, as amended, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. The financial
statements of the Company included in the SEC Reports, as amended, comply in
all material respects with applicable accounting requirements and the rules and
regulations of the Commission with respect thereto as in effect at the time of
filing. Such financial statements have been prepared in accordance with GAAP
applied on a consistent basis during the periods 

 7
 

    involved, except as may be otherwise specified in such
financial statements or the notes thereto, and fairly present in all material
respects the financial position of the Company and its consolidated Subsidiaries
as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to
normal, year-end audit adjustments.
  (i)            Material Changes.  Since the date of the latest audited
financial statements included within the SEC Reports, except as specifically
disclosed in the SEC Reports, (i) there has been no event, occurrence or
development that has had or that could reasonably be expected to result in a
Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables, accrued expenses and
other liabilities incurred in the ordinary course of business consistent with
past practice and (B) liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or required to be disclosed in filings
made with the Commission, (iii) the Company has not altered its method of
accounting or the identity of its auditors, (iv) the Company has not declared
or made any dividend or distribution of cash or other property to its
stockholders or purchased, redeemed or made any agreements to purchase or
redeem any shares of its capital stock (other than in connection with
repurchases of unvested stock issued to employees of the Company), and (v) the
Company has not issued any equity securities to any officer, director or
Affiliate, except pursuant to existing Company stock option plans.
  (j)            Litigation.  There is no Action which (i) adversely
affects or challenges the legality, validity or enforceability of any of the
Transaction Documents or the Securities or (ii) except as specifically
disclosed in the SEC Reports, could, if there were an unfavorable decision,
individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect. Neither the Company nor any Subsidiary, nor any
director or officer thereof (in his or her capacity as such), is or has been
the subject of any Action involving a claim of violation of or liability under
federal or state securities laws or a claim of breach of fiduciary duty, except
as specifically disclosed in the SEC Reports. There has not been, and to the
knowledge of the Company, there is not pending any investigation by the
Commission involving the Company or any current or former director or officer
of the Company (in his or her capacity as such). The Commission has not issued
any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the
Securities Act.
  (k)           Compliance.  Neither the Company nor any Subsidiary (i) is
in default under or in violation of (and no event has occurred that has not
been waived that, with notice or lapse of time or both, would result in a
default by the Company or any Subsidiary under), nor has the Company or any
Subsidiary received notice of a claim that it is in default under or that it is
in violation of, any indenture, loan or credit agreement or any other agreement
or instrument to which it is a party or by which it or any of its properties is
bound (whether or not such default or violation has been waived), (ii) is in
violation of, or in receipt of notice that it is in violation of, any order of
any court, arbitrator or governmental body, or (iii) is or has been in
violation of, or in receipt of notice that it is in violation of, any statute,
rule or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, 

 8
 

    environmental protection, occupational health and
safety, product quality and safety, employment and labor matters and, to its
knowledge, privacy, except in each case as could not, individually or in the
aggregate, have or reasonably be expected to result in a Material Adverse
Effect. The Company is in compliance with all effective requirements of the
Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations
thereunder, that are applicable to it, except where such noncompliance could
not have or reasonably be expected to result in a Material Adverse Effect.
  (l)            Regulatory
Permits.  Except as set forth on Schedule
3.1(l), the Company and the Subsidiaries possess all certificates,
authorizations and permits issued by the appropriate federal, state, local or
foreign regulatory authorities necessary to conduct their respective businesses
as described in the SEC Reports, except where the failure to possess such
permits could not, individually or in the aggregate, have or reasonably be
expected to result in a Material Adverse Effect, and neither the Company nor
any Subsidiary has received any notice of proceedings relating to the
revocation or modification of any such permits.
  (m)          Title to Assets.  The Company and the Subsidiaries have good
and marketable title in fee simple to all real property owned by them that is
material to their respective businesses and good and marketable title in all
personal property owned by them that is material to their respective
businesses, in each case free and clear of all Liens, except for Liens as do
not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the
Company and the Subsidiaries. Any real property and facilities held under lease
by the Company and the Subsidiaries are held by them under leases valid,
subsisting and enforceable against the Company and the Subsidiaries, and the
Company and the Subsidiaries are in compliance with such leases, except as
could not, individually or in the aggregate, have or reasonably be expected to
result in a Material Adverse Effect.
  (n)           Patents and
Trademarks.  The Company and the
Subsidiaries have, or have rights to use, all patents, patent applications,
trademarks, trademark applications, service marks, trade names, copyrights,
licenses and other similar rights that are necessary or material for use in
connection with their respective businesses as described in the SEC Reports and
which the failure to so have could, individually or in the aggregate, have or
reasonably be expected to result in a Material Adverse Effect (collectively,
the “Intellectual Property
Rights”). Neither the Company nor any Subsidiary has
received a written notice that the Intellectual Property Rights used by the
Company or any Subsidiary violates or infringes upon the rights of any Person
and the Company has no knowledge of any such violation or infringement. Except
as set forth in the SEC Reports, to the knowledge of the Company, all such
Intellectual Property Rights are enforceable.
  (o)           Insurance.  The Company and the Subsidiaries are insured
by insurers of recognized financial responsibility against such losses and
risks and in such amounts as are prudent and customary for enterprises of
similar size and stage of development in the businesses in which the Company
and the Subsidiaries are engaged. The Company has no reason to believe that it
will not be able to renew its and the Subsidiaries’ existing insurance coverage
as and when 

 9
 

    such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business on terms
consistent with market for the Company’s and such Subsidiaries’ respective
lines of business.
  (p)           Transactions With
Affiliates and Employees.  Except as
set forth in the SEC Reports, none of the officers or directors of the Company
and, to the knowledge of the Company, none of the employees of the Company is
presently a party to any transaction with the Company or any Subsidiary
required to be disclosed in the SEC Reports (other than for services as
employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for
rental of real or personal property to or from, or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the
Company, any entity in which any officer, director, or any such employee has a
substantial interest or is an officer, director, trustee or partner.
  (q)           Internal Accounting
Controls.  The Company and the
Subsidiaries maintain a system of internal accounting controls sufficient to
provide reasonable assurance that (i) transactions are executed in accordance
with management’s general or specific authorizations, (ii) transactions are
recorded as necessary to permit preparation of financial statements in
conformity with GAAP and to maintain asset accountability, (iii) access to
assets is permitted only in accordance with management’s general or specific
authorization, and (iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences. The Company has established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the Company and designed such disclosure controls and procedures
to ensure that material information relating to the Company, including its
Subsidiaries, is made known to the certifying officers by others within those
entities. The Company’s certifying officers have evaluated the effectiveness of
the Company’s controls and procedures in accordance with Item 307 of Regulation
S-B under the Exchange Act for the Company’s fiscal quarter ended September 30,
2006 (such date, the “Evaluation
Date”). The Company presented in its most recently filed
Form 10-QSB the conclusions of the certifying officers about the effectiveness
of the disclosure controls and procedures based on their evaluations as of the
Evaluation Date. Since the Evaluation Date, there have been no significant
changes in the Company’s internal controls (as such term is defined in Item
308(c) of Regulation S-B under the Exchange Act) or, to the Company’s
knowledge, in other factors that could significantly affect the Company’s
internal controls which was required to be disclosed in the SEC Reports and was
not so disclosed.
  (r)            Certain Fees.  No agent or broker will receive brokerage or
finder fees or commissions payable by the Company with respect to the transactions
contemplated by this Agreement. The Investors shall have no obligation with
respect to any fees or with respect to any claims (other than such fees or
commissions owed by an Investor pursuant to written agreements executed by such
Investor which fees or commissions shall be the sole responsibility of such
Investor) made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions
contemplated by this Agreement.

 10

(s)           Certain
Registration Matters. Assuming the accuracy of the Investors’
representations and warranties set forth in Section 3.2(b)-(e), no registration
under the Securities Act is required for the offer and sale of the Shares by
the Company to the Investors under the Transaction Documents.

(t)            Listing and
Maintenance Requirements.  Except as
specified in the SEC Reports, the Company has not, in the two years preceding
the date hereof, received notice from any Trading Market to the effect that the
Company is not in compliance with the listing or maintenance requirements
thereof.  The Company is, and has no
reason to believe that it will not in the foreseeable future continue to be, in
compliance with the listing and maintenance requirements for continued listing
of the Common Stock on the Trading Market on which the Common Stock is
currently listed or quoted.  The issuance
and sale of the Securities under the Transaction Documents does not contravene
the rules and regulations of the Trading Market on which the Common Stock is
currently listed or quoted, and no approval of the shareholders of the Company
thereunder is required for the Company to issue and deliver to the Investors
the Securities contemplated by Transaction Documents.

(u)           Investment
Company.  The Company is not, and is
not an Affiliate of, and immediately following the Closing will not have
become, an “investment company” within the meaning of the Investment Company
Act of 1940, as amended.

(v)           Application of
Takeover Protections.  The Company has
taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any
distribution under a rights agreement) or other similar anti-takeover
provision under the Company’s Certificate of Incorporation (or similar charter
documents) or the laws of its state of incorporation that is or could become
applicable to the Investors as a result of the Investors and the Company
fulfilling their obligations or exercising their rights under the Transaction
Documents, including without limitation the Company’s issuance of the
Securities and the Investors’ ownership of the Securities.

(w)          No Additional
Agreements.  The Company does not
have any agreement or understanding with any Investor with respect to the
transactions contemplated by the Transaction Documents other than as specified
in the Transaction Documents.

(x)            Disclosure.  The Company confirms that neither it nor any
Person acting on its behalf has provided any Investor or its respective agents
or counsel with any information that the Company believes constitutes material,
non-public information except insofar as the existence and terms of the
proposed transactions hereunder may constitute such information. The Company
understands and confirms that the Investors will rely on the foregoing
representations and covenants in effecting transactions in securities of the
Company.  All disclosure provided to the
Investors regarding the Company, its business and the transactions contemplated
hereby, furnished by or on behalf of the Company (including the Company’s
representations and warranties set forth in this Agreement) are true and
correct and do not contain any untrue statement of a material fact or omit to
state any material fact necessary in order to make the 

 11
 

statements made therein, in light of the circumstances
under which they were made, not misleading.

(y)           Insolvency.  The Company is not as of the date hereof, and
after giving effect to the transactions contemplated hereby to occur at the
Closing will not, be Insolvent.  For
purposes of this Agreement, “Insolvent” shall mean, with respect to any Person,
that (i) such Person is unable to pay its debts and liabilities, subordinated,
contingent or otherwise, as such debts and liabilities become absolute and
matured or (ii) such Person intends to incur or believes that it will incur
debts that would be beyond its ability to pay as such debts mature.

(z)            Transfer Taxes.  On the Closing Date, all stock transfer or
other taxes (other than income or similar taxes) which are required to be paid
in connection with the sale and transfer of the Securities to be sold to each
Investor hereunder will be, or will have been, fully paid or provided for by
the Company, and all laws imposing such taxes will be or will have been
complied with by the Company, except where such noncompliance could not have or
reasonably be expected to result in a Material Adverse Effect.

(aa)         Tax Status.  Except as set forth on Schedule 3.1(aa),
the Company and each of its Subsidiaries (i) has made or filed all foreign,
federal and state income and all other tax returns, reports and declarations
required by any jurisdiction to which it is subject, (ii) has paid all taxes
and other governmental assessments and charges that are material in amount,
shown or determined to be due on such returns, reports and declarations, except
those being contested in good faith and (iii) has set aside on its books
provision reasonably adequate for the payment of all taxes for periods
subsequent to the periods to which such returns, reports or declarations apply,
except where the failure to do so could not have or reasonably be expected to
result in a Material Adverse Effect. 
There are no unpaid taxes in any material amount claimed to be due by
the taxing authority of any jurisdiction, and the officers of the Company know
of no basis for any such claim.

(bb)         Undisclosed
Liabilities.  No event, liability,
development or circumstance has occurred or exists with respect to the Company
or its respective business, properties, prospects, operations or financial
condition, that would be required to be disclosed by the Company under the
Securities Act and the Exchange Act and the rules and regulations of the
Commission promulgated thereunder relating to an issuance and sale by the
Company of its securities and which has not been reported in accordance with
such rules and regulations of the Commission.

(cc)         Employee Relations.  Neither Company nor any of its Subsidiaries
is a party to any collective bargaining agreement or employs any member of a
union.  The Company and its Subsidiaries
believe that their relations with their employees are good.  No executive officer of the Company or any of
its Subsidiaries (as defined in Rule 501(f) of the Securities Act) has notified
the Company or any such Subsidiary that such officer intends to leave the
Company or any such Subsidiary or otherwise terminate such officer’s employment
with the Company or any such Subsidiary. 
No executive officer of the Company or any of its Subsidiaries, to the
knowledge of the Company or any such Subsidiary, is now, or expects to be, in
violation of any 

 12
 

material term of any employment contract,
confidentiality, disclosure or proprietary information agreement,
non-competition agreement, or any other contract, agreement or any restrictive
covenant, and the continued employment of each such executive officer does not
subject the Company or any such Subsidiary to any liability with respect to any
of the foregoing matters.  The Company
and its Subsidiaries are in compliance with all federal, state and local laws
and regulations respecting labor, employment and employment practices and
benefits, terms and conditions of employment and wages and hours, except where
failure to be in compliance would not, either individually or in the aggregate,
reasonably be expected to result in a Material Adverse Effect.  There are no complaints or charges against
the Company or its Subsidiaries pending or, to the knowledge of the Company and
its Subsidiaries, threatened to be filed with any Governmental Authority or
arbitrator based on, arising out of, in connection with, or otherwise relating
to the employment or termination of employment by the Company or its
Subsidiaries of any individual, that would be reasonably likely to result in a
Material Adverse Effect.

(dd)         Subsidiary Rights.  The Company or one of its Subsidiaries has
the unrestricted right to vote, and (subject to limitations imposed by
applicable law) to receive dividends and distributions on, all capital securities
of its Subsidiaries as owned by the Company or such Subsidiary.

(ee)         Off Balance Sheet
Arrangements.  There is no
transaction, arrangement, or other relationship between the Company and an
unconsolidated or other off balance sheet entity that is required to be
disclosed by the Company in its SEC Reports and is not so disclosed or that
otherwise would be reasonably likely to have a Material Adverse Effect.

3.2           Representations
and Warranties of the Investors. 
Each Investor hereby, for itself and for no other Investor, represents
and warrants to the Company as follows:

(a)           Organization;
Authority.  Such Investor is an
entity duly organized, validly existing and in good standing under the laws of
the jurisdiction of its organization with the requisite corporate or
partnership power and authority to enter into and to consummate the
transactions contemplated by the applicable Transaction Documents and otherwise
to carry out its obligations thereunder. The execution, delivery and
performance by such Investor of the transactions contemplated by this Agreement
has been duly authorized by all necessary corporate or, if such Investor is not
a corporation, such partnership, limited liability company or other applicable
like action, on the part of such Investor. 
Each of this Agreement and the Registration Rights Agreement has been
duly executed by such Investor, and when delivered by such Investor in
accordance with terms hereof, will constitute the valid and legally binding
obligation of such Investor, enforceable against it in accordance with its
terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating
to, or affecting generally the enforcement of, creditors’ rights and remedies
or by other equitable principles of general application.

(b)           Investment Intent.  Such Investor is acquiring the Securities as
principal for its own account for investment purposes only and not with a view
to or for distributing or 

 13
 

reselling such Securities or any part thereof, without
prejudice, however, to such Investor’s right at all times to sell or otherwise
dispose of all or any part of such Securities in compliance with applicable
federal and state securities laws. 
Subject to the immediately preceding sentence, nothing contained herein
shall be deemed a representation or warranty by such Investor to hold the
Securities for any period of time.  Such
Investor is acquiring the Securities hereunder in the ordinary course of its
business. Such Investor does not have any agreement or understanding, directly
or indirectly, with any Person to distribute any of the Securities.

(c)           Investor Status.  At the time such Investor was offered the
Securities, it was, and at the date hereof it is, an “accredited investor” as
defined in Rule 501(a) under the Securities Act.  Such Investor is not a registered
broker-dealer under Section 15 of the Exchange Act.

(d)           General
Solicitation.  Such Investor is not
purchasing the Securities as a result of any advertisement, article, notice or
other communication regarding the Securities published in any newspaper,
magazine or similar media or broadcast over television or radio or presented at
any seminar or any other general solicitation or general advertisement.

(e)           Access to
Information.  Such Investor
acknowledges that it has reviewed the Disclosure Materials and has been
afforded (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the
terms and conditions of the offering of the Shares and the merits and risks of
investing in the Securities; (ii) access to information about the Company and
the Subsidiaries and their respective financial condition, results of operations,
business, properties, management and prospects sufficient to enable it to
evaluate its investment; and (iii) the opportunity to obtain such additional
information that the Company possesses or can acquire without unreasonable
effort or expense that is necessary to make an informed investment decision
with respect to the investment.  Neither
such inquiries nor any other investigation conducted by or on behalf of such
Investor or its representatives or counsel shall modify, amend or affect such
Investor’s right to rely on the truth, accuracy and completeness of the
Disclosure Materials and the Company’s representations and warranties contained
in the Transaction Documents.

(f)            Certain Trading
Activities.  Such Investor has not
directly or indirectly, nor has any Person acting on behalf of or pursuant to
any understanding with such Investor, engaged in any transactions in the
securities of the Company (including, without limitations, any Short Sales
involving the Company’s securities) since the time that such Investor was first
contacted by the Company regarding the investment in the Company contemplated
by this Agreement.  Such Investor
covenants that neither it nor any Person acting on its behalf or pursuant to any
understanding with it will engage in any transactions in the securities of the
Company (including Short Sales) prior to the time that the transactions
contemplated by this Agreement are publicly disclosed by the Company.  Such Investor has maintained, and covenants
that until such time as the transactions contemplated by this Agreement are
publicly disclosed by the Company such Investor will maintain, the
confidentiality of any disclosures made to it in connection with this
transaction (including the existence and terms of this transaction).  Such Investor understands and acknowledges,
that the Commission currently takes 

 14
 

the position that coverage of Short Sales “against the
box” prior to the Effective Date of the Registration Statement is a violation
of Section 5 of the Securities Act, as set forth in Item 65, Section A, of the
Manual of Publicly Available Telephone Interpretations, dated July 1997,
compiled by the Office of Chief Counsel, Division of Corporation Finance.

(g)           Independent
Investment Decision.  Such Investor
has independently evaluated the merits of its decision to purchase Securities
pursuant to the Transaction Documents, and such Investor confirms that it has
not relied on the advice of any other Investor’s business and/or legal counsel
in making such decision.  Such Investor
has not relied on the business or legal advice of the Company or any of its
agents, counsel or Affiliates in making its investment decision hereunder, and
confirms that none of such Persons has made any representations or warranties
to such Investor in connection with the transactions contemplated by the
Transaction Documents.

(h)           [Reserved]

The Company
acknowledges and agrees that no Investor has made or makes any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in this Section 3.2.

ARTICLE
IV.

OTHER AGREEMENTS OF THE PARTIES

Section 4.1             (a)           Securities may only be disposed of in
compliance with state and federal securities laws.  In connection with any transfer of the
Securities other than pursuant to an effective registration statement, to the
Company, to an Affiliate of an Investor or in connection with a pledge as
contemplated in Section 4.1(b), the Company may require the transferor thereof
to provide to the Company an opinion of counsel selected by the transferor, the
form and substance of which opinion shall be reasonably satisfactory to the
Company, to the effect that such transfer does not require registration of such
transferred Securities under the Securities Act.

(b)           Certificates
evidencing the Securities will contain the following legend, until such time as
they are not required under Section 4.1(c):

THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT
OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A 

 15
 

LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH
EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY.  THESE SECURITIES MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

The Company acknowledges and agrees that an Investor may from time to
time pledge, and/or grant a security interest in some or all of the Securities
pursuant to a bona fide margin agreement in connection with a bona fide margin
account and, if required under the terms of such agreement or account, such
Investor may transfer pledged or secured Securities to the pledgees or secured
parties.  Such a pledge or transfer would
not be subject to approval or consent of the Company and no legal opinion of
legal counsel to the pledgee, secured party or pledgor shall be required in
connection with the pledge, but such legal opinion may be required in
connection with a subsequent transfer following default by the Investor
transferee of the pledge.  No notice
shall be required of such pledge.  At the
appropriate Investor’s expense, the Company will execute and deliver such
reasonable documentation as a pledgee or secured party of Securities may
reasonably request in connection with a pledge or transfer of the Securities
including the preparation and filing of any required prospectus supplement under
Rule 424(b)(3) of the Securities Act or other applicable provision of the
Securities Act to appropriately amend the list of Selling Stockholders
thereunder.

(c)           Certificates
evidencing the Shares shall not contain any legend (including the legend set
forth in Section 4.1(b)): (i) following a sale or transfer of such Shares
pursuant to an effective registration statement (including the Registration
Statement), or (ii) following a sale or transfer of such Shares pursuant to
Rule 144 (assuming the transferor is not an Affiliate of the Company), or (iii)
while such Shares are eligible for sale under Rule 144(k), or (iv) if such
legend is not required under applicable requirements of the Securities Act
(including judicial interpretations and pronouncements issued by the Staff of
the Commission).  Upon the earlier of (i)
the Effective Date or (ii) Rule 144(k) becoming available for the resale of
Registrable Securities, Company shall (A) deliver to the transfer agent for the
Common Stock (the “Transfer
Agent”) irrevocable instructions that the Transfer Agent shall
reissue a certificate representing shares of Common Stock without legends upon
receipt by such Transfer Agent of the legended certificates for such shares,
together with either (1) a customary representation by the Investor that Rule
144(k) applies to the shares of Common Stock represented thereby or (2) a
statement by the Investor that such Investor has sold the shares of Common
Stock represented thereby in accordance with the Plan of Distribution contained
in the Registration Statement, and (B) cause its counsel to deliver to the
Transfer Agent one or more blanket opinions to the effect that the removal of
such legends in such circumstances may be effected under the Securities Act.  From and after the earlier of such dates,
upon an Investor’s written request, the Company shall promptly cause
certificates evidencing the Investor’s Shares to be replaced with certificates
which do not bear such restrictive legends. 
When the Company is required to cause unlegended certificates to replace
previously issued legended certificates under this Section, if unlegended
certificates are not delivered to an Investor within three (3) Trading Days of
submission by that Investor of legended certificate(s) to the Transfer Agent as
provided above (the “Delivery
Date”), and if after such Delivery Date and prior to the receipt
of such unlegended certificates, 

 16
 

the Investor or the Investor’s broker purchases (in an
open market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Investor of the Shares which the Investor
anticipated receiving upon such request (a “Buy
In”), then the Company shall (1) pay in cash to the Investor the
amount by which (x) the Investor’s total purchase price (including reasonable
brokerage commissions, if any) for the shares of Common Stock so purchased
exceeds (y) the amount obtained by multiplying (A) the number of Shares that
the Company was required to deliver to the Investor on the Delivery Date by (B)
the closing bid price of the Common Stock on the Delivery Date and (2) deliver
to such Investor the number of shares of Common Stock that would have been
issued had the Company timely complied with its delivery obligations hereunder.  The Investor shall provide the Company
written notice indicating the amounts payable to the Investor in respect of the
Buy In.

Section 4.2             Furnishing
of Information.  As long as any
Investor owns the Securities, the Company covenants to timely file (or obtain
extensions in respect thereof and file within the applicable grace period) all
reports required to be filed by the Company after the date hereof pursuant to
the Exchange Act.  As long as any
Investor owns Securities, if the Company is not required to file reports
pursuant to such laws, it will prepare and furnish to the Investors and make
publicly available in accordance with Rule 144(c) such information as is
required for the Investors to sell the Shares under Rule 144. The Company
further covenants that it will take such further action as any holder of
Securities may reasonably request, all to the extent required from time to time
to enable such Person to sell the Shares without registration under the
Securities Act within the limitation of the exemptions provided by Rule 144.

Section 4.3             Integration.  The Company shall not, and shall use its best
efforts to ensure that no Affiliate of the Company shall, sell, offer for sale
or solicit offers to buy or otherwise negotiate in respect of any security (as
defined in Section 2 of the Securities Act) that would be integrated with the
offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the sale of the Securities to the Investors, or
that would be integrated with the offer or sale of the Securities for purposes
of the rules and regulations of any Trading Market in a manner that would
require stockholder approval of the sale of the securities to the Investors.

Section 4.4             Securities
Laws Disclosure; Publicity.  By 9:00
a.m. (New York time) on the Trading Day following the execution of this
Agreement, and by 9:00 a.m. (New York time) on the Trading Day following the
Closing Date, the Company shall issue press releases disclosing the
transactions contemplated hereby and the Closing.  On the Trading Day following the execution of
this Agreement the Company will file a Current Report on Form 8-K disclosing
the material terms of the Transaction Documents (and attach as exhibits thereto
the Transaction Documents), and on the Trading Day following the Closing Date
the Company will file an additional Current Report on Form 8-K to disclose the
Closing.  In addition, the Company will
make such other filings and notices in the manner and time required by the Commission
and the Trading Market on which the Common Stock is listed.  Notwithstanding the foregoing, the Company
shall not publicly disclose the name of any Investor, or include the name of
any Investor in any filing with the Commission (other than the Registration
Statement and any exhibits to filings made in respect of this transaction in
accordance with periodic filing 

 17
 

requirements under the Exchange Act) or any regulatory
agency or Trading Market, without the prior written consent of such Investor,
except to the extent such disclosure is required by law or Trading Market
regulations.

Section 4.5             [Reserved]

Section 4.6             Indemnification
of Investors.  In addition to the
indemnity provided in the Registration Rights Agreement, the Company will
indemnify and hold the Investors and their directors, officers, shareholders,
partners, employees, Affiliates and agents (each, an “Investor Party”)
harmless from any and all losses, liabilities, obligations, claims,
contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys’ fees and costs of
investigation (collectively, “Losses”) that any such Investor
Party may suffer or incur as a result of or relating to any misrepresentation,
breach or inaccuracy of any representation, warranty, covenant or agreement
made by the Company in any Transaction Document.  In addition to the indemnity contained
herein, the Company will reimburse each Investor Party for its reasonable legal
and other expenses (including the cost of any investigation, preparation and
travel in connection therewith) incurred in connection therewith, as such
expenses are incurred.

Section 4.7             Non-Public
Information.  The Company covenants
and agrees that neither it nor any other Person acting on its behalf will
provide any Investor or its agents or counsel with any information that the
Company believes constitutes material non-public information, unless prior
thereto such Investor shall have executed a written agreement regarding the
confidentiality and use of such information. 
The Company understands and confirms that each Investor shall be relying
on the foregoing covenant and agreement in effecting transactions in securities
of the Company.

Section 4.8             Listing
of Securities.  The Company agrees,
(i) if the Company applies to have the Common Stock traded on any other Trading
Market, it will include in such application the Shares, and will take such
other action as is necessary or desirable to cause the Shares to be listed on
such other Trading Market as promptly as possible, and (ii) it will take all
action reasonably necessary to continue the listing and trading of its Common
Stock on a Trading Market and will comply in all material respects with the
Company’s reporting, filing and other obligations under the bylaws or rules of
the Trading Market.

Section 4.9             Use of
Proceeds.  The Company will use the
net proceeds from the sale of the Securities hereunder for general corporate
purposes, which may include working capital and reduction of contractual
obligations.

ARTICLE
V.

CONDITIONS PRECEDENT TO CLOSING

Section 5.1             Conditions
Precedent to the Obligations of the Investors to Purchase Securities.  The obligation of each Investor to acquire
Securities at the Closing is subject to the satisfaction or waiver by such
Investor, at or before the Closing, of each of the following conditions:

 18
 

(a)           Representations
and Warranties.  The representations
and warranties of the Company contained herein shall be true and correct in all
material respects as of the date when made and as of the Closing as though made
on and as of such date, except that representations and warranties that are
qualified by materiality shall be true and correct as of the date when made and
as of the Closing as though made on and as of such date;

(b)           Performance.  The Company shall have performed, satisfied
and complied in all material respects with all covenants, agreements and
conditions required by the Transaction Documents to be performed, satisfied or
complied with by it at or prior to the Closing;

(c)           No Injunction.  No statute, rule, regulation, executive
order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent
jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents;

(d)           Adverse Changes.  Since the date of execution of this
Agreement, no event or series of events shall have occurred that reasonably
could have or result in a Material Adverse Effect;

(e)           No Suspensions of
Trading in Common Stock; Listing. 
Trading in the Common Stock shall not have been suspended by the
Commission or any Trading Market (except for any suspensions of trading of not
more than one Trading Day solely to permit dissemination of material information
regarding the Company) at any time since the date of execution of this
Agreement, and the Common Stock shall have been at all times since such date
listed for trading on a Trading Market;

(f)            [Reserved];

(g)           Company
Deliverables.  The Company shall have
delivered the Company Deliverables in accordance with Section 2.2(a); and

(h)           Termination.  This Agreement shall not have been terminated
as to such Investor in accordance with Section 6.5 herein.

Section 5.2             Conditions
Precedent to the Obligations of the Company to sell Securities.  The obligation of the Company to sell
Securities at the Closing is subject to the satisfaction or waiver by the
Company, at or before the Closing, of each of the following conditions:

(a)           Representations
and Warranties.  The representations
and warranties of each Investor contained herein shall be true and correct in
all material respects as of the date when made and as of the Closing Date as
though made on and as of such date;

(b)           Performance.  Each Investor shall have performed, satisfied
and complied in all material respects with all covenants, agreements and
conditions required by the Transaction Documents to be performed, satisfied or
complied with by such Investor at or prior to the Closing;

 19
 

(c)           No Injunction.  No statute, rule, regulation, executive
order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent
jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents;

(d)           [Reserved];

(e)           Investors
Deliverables.  Each Investor shall
have delivered its Investors Deliverables in accordance with Section 2.2(b);
and

(f)            Termination.  This Agreement shall not have been terminated
as to such Investor in accordance with Section 6.5 herein.

ARTICLE
VI.

MISCELLANEOUS

Section 6.1             Fees
and Expenses.  Each party shall pay
the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of the
Transaction Documents.  The Company shall
pay all stamp and other taxes and duties levied in connection with the sale of
the Shares.

Section 6.2             Entire
Agreement.  The Transaction
Documents, together with the Exhibits and Schedules thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and
supersede all prior agreements, understandings, discussions and
representations, oral or written, with respect to such matters, which the
parties acknowledge have been merged into such documents, exhibits and
schedules.

Section 6.3             Notices.  Any and all notices or other communications
or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of (a) the date
of transmission, if such notice or communication is delivered via facsimile
(provided the sender receives a machine-generated confirmation of successful
transmission and reasonably promptly following such transmission sends such
notice or communication via U.S. mail or overnight courier) at the facsimile
number specified in this Section prior to 5:00 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number
specified in this Section on a day that is not a Trading Day or later than 5:00
p.m. (New York City time) on any Trading Day, (c) the Trading Day following the
date of mailing, if sent by U.S. nationally recognized overnight courier
service, or (d) upon actual receipt by the party to whom such notice is
required to be given.  The address for
such notices and communications shall be as follows:

	
  If to the Company:

  	
   

  	
  Crdentia Corp.

  
	
   

  	
   

  	
  5001 LBJ Freeway, Suite 850

  
	
   

  	
   

  	
  Dallas, Texas 75244

  
	
   

  	
   

  	
  Facsimile No.: (972) 850-0780

  
	
  

  	
   

  	
  Telephone No.: (972) 392-2722

  	 

	
   

  	
   

  	
  Attention: Chief Executive Officer

  	 

						

 

 20
 

 

	
  With a copy to:

  	
   

  	
  Morrison & Foerster LLP

  
	
   

  	
   

  	
  12531 High Bluff Drive, Suite 100

  
	
   

  	
   

  	
  San Diego, CA 92130

  
	
   

  	
   

  	
  Facsimile No.:  (858) 720-5125

  
	
   

  	
   

  	
  Attention:  Steven G. Rowles, Esq.

  
	
   

  	
   

  	
   

  
	
  If to an
  Investor:

  	
   

  	
  To the address set forth under such Investor’s

  name on the signature pages hereof

  

 

or such other address as
may be designated in writing hereafter, in the same manner, by such Person.

Section 6.4             Amendments;
Waivers; No Additional Consideration. 
No provision of this Agreement may be waived or amended except in a
written instrument signed by the Company and the Investors holding a majority
of the Shares.  No waiver of any default
with respect to any provision, condition or requirement of this Agreement shall
be deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition or requirement hereof,
nor shall any delay or omission of either party to exercise any right hereunder
in any manner impair the exercise of any such right.  No consideration shall be offered or paid to
any Investor to amend or consent to a waiver or modification of any provision
of any Transaction Document unless the same consideration is also offered to all
Investors who then hold Shares.

Section 6.5             Termination.  This Agreement may be terminated prior to
Closing:

(a)           by written agreement
of the Investors and the Company; and

(b)           by the Company or an
Investor (as to itself but no other Investor) upon written notice to the other,
if the Closing shall not have taken place by 5:00 p.m. (New York City time) on
the Outside Date; provided, that the right to terminate this Agreement
under this Section 6.5(b) shall not be available to any Person whose
failure to comply with its obligations under this Agreement has been the cause
of or resulted in the failure of the Closing to occur on or before such time.

In the event of a termination pursuant to this Section, the Company
shall promptly notify all non-terminating Investors. Upon a termination in
accordance with this Section 6.5, the Company and the terminating Investor(s)
shall not have any further obligation or liability (including as arising from
such termination) to the other and no Investor will have any liability to any
other Investor under the Transaction Documents as a result therefrom.

Section 6.6             Construction.  The headings herein are for convenience only,
do not constitute a part of this Agreement and shall not be deemed to limit or
affect any of the provisions hereof.  The
language used in this Agreement will be deemed to be the language 

 21
 

chosen by the parties to express their mutual intent,
and no rules of strict construction will be applied against any party.  This Agreement shall be construed as if drafted
jointly by the parties, and no presumption or burden of proof shall arise
favoring or disfavoring any party by virtue of the authorship of any provisions
of this Agreement or any of the Transaction Documents.

Section 6.7             Successors
and Assigns.  This Agreement shall be
binding upon and inure to the benefit of the parties and their successors and
permitted assigns.  Other than in
connection with a merger, consolidation, sale of all or substantially all of
the Company’s assets or other similar change in control transaction, the
Company may not assign this Agreement or any rights or obligations hereunder
without the prior written consent of the Investors. Any Investor may assign any
or all of its rights under this Agreement to any Person to whom such Investor
assigns or transfers any Securities, provided such transferee agrees in writing
to be bound, with respect to the transferred Securities, by the provisions
hereof that apply to the “Investors.”

Section 6.8             No
Third-Party Beneficiaries.  This
Agreement is intended for the benefit of the parties hereto and their
respective successors and permitted assigns and is not for the benefit of, nor
may any provision hereof be enforced by, any other Person, except as otherwise
set forth in Section 4.7 (as to each Investor Party).

Section 6.9             Governing
Law.  All questions concerning the
construction, validity, enforcement and interpretation of this Agreement shall
be governed by and construed and enforced in accordance with the internal laws
of the State of New York, without regard to the principles of conflicts of law
thereof.  Each party agrees that all
Proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Agreement and any other Transaction Documents
(whether brought against a party hereto or its respective Affiliates, employees
or agents) shall be commenced exclusively in the New York Courts.  Each party hereto hereby irrevocably submits
to the exclusive jurisdiction of the New York Courts for the adjudication of
any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the
enforcement of the any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Proceeding, any claim that it is not
personally subject to the jurisdiction of any such New York Court, or that such
Proceeding has been commenced in an improper or inconvenient forum.  Each party hereto hereby irrevocably waives
personal service of process and consents to process being served in any such
Proceeding by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in
effect for notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice
thereof.  Nothing contained herein shall
be deemed to limit in any way any right to serve process in any manner
permitted by law.  Each party hereto
hereby irrevocably waives, to the fullest extent permitted by applicable law,
any and all right to trial by jury in any legal proceeding arising out of or
relating to this Agreement or the transactions contemplated hereby.  If either party shall commence a Proceeding to
enforce any provisions of a Transaction Document, then the prevailing party in
such Proceeding shall be reimbursed by the other party for its reasonable
attorneys’ fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Proceeding.

 22

Section 6.10           Survival.  The agreements, covenants, representation and warranties
contained herein shall survive the Closing and the delivery of the Securities.

Section 6.11           Execution.  This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and the
same agreement and shall become effective when counterparts have been signed by
each party and delivered to the other party, it being understood that both
parties need not sign the same counterpart. 
In the event that any signature is delivered by facsimile transmission,
such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force
and effect as if such facsimile signature page were an original thereof.

Section 6.12           Severability.  If any provision of this Agreement is held to
be invalid or unenforceable in any respect, the validity and enforceability of
the remaining terms and provisions of this Agreement shall not in any way be
affected or impaired thereby and the parties will attempt to agree upon a valid
and enforceable provision that is a reasonable substitute therefor, and upon so
agreeing, shall incorporate such substitute provision in this Agreement.

Section 6.13           Rescission
and Withdrawal Right. 
Notwithstanding anything to the contrary contained in (and without
limiting any similar provisions of) the Transaction Documents, whenever any
Investor exercises a right, election, demand or option under a Transaction Document
and the Company does not timely perform its related obligations within the
periods therein provided, then such Investor may rescind or withdraw, in its
sole discretion from time to time upon written notice to the Company, any
relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights.

Section 6.14           Replacement
of Securities.  If any certificate or
instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for
and upon cancellation thereof, or in lieu of and substitution therefor, a new
certificate or instrument, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction and customary
and reasonable indemnity, if requested. 
The applicants for a new certificate or instrument under such
circumstances shall also pay any reasonable third-party costs associated with
the issuance of such replacement Securities. 
If a replacement certificate or instrument evidencing any Securities is
requested due to a mutilation thereof, the Company may require delivery of such
mutilated certificate or instrument as a condition precedent to any issuance of
a replacement.

Section 6.15           Remedies.  In addition to being entitled to exercise all
rights provided herein or granted by law, including recovery of damages, each
of the Investors and the Company will be entitled to specific performance under
the Transaction Documents.  The parties
agree that monetary damages may not be adequate compensation for any loss
incurred by reason of any breach of obligations described in the foregoing
sentence and hereby agrees to waive in any action for specific performance of
any such obligation the defense that a remedy at law would be adequate.

Section 6.16           Payment
Set Aside.  To the extent that the
Company makes a payment or payments to any Investor pursuant to any Transaction
Document or an Investor enforces or 

 23
 

exercises its rights thereunder, and such payment or
payments or the proceeds of such enforcement or exercise or any part thereof
are subsequently invalidated, declared to be fraudulent or preferential, set
aside, recovered from, disgorged by or are required to be refunded, repaid or
otherwise restored to the Company, a trustee, receiver or any other person
under any law (including, without limitation, any bankruptcy law, state or
federal law, common law or equitable cause of action), then to the extent of
any such restoration the obligation or part thereof originally intended to be
satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.

Section 6.17           Independent
Nature of Investors’ Obligations and Rights.  The obligations of each Investor under any
Transaction Document are several and not joint with the obligations of any
other Investor, and no Investor shall be responsible in any way for the
performance of the obligations of any other Investor under any Transaction
Document.  The decision of each Investor
to purchase Securities pursuant to the Transaction Documents has been made by
such Investor independently of any other Investor.  Each Investor’s obligations hereunder are
expressly not conditioned on the purchase by any or all of the other Investors
of the Shares.  Nothing contained herein
or in any Transaction Document, and no action taken by any Investor pursuant
thereto, shall be deemed to constitute the Investors as a partnership, an
association, a joint venture or any other kind of entity, or create a
presumption that the Investors are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the
Transaction Documents.  Each Investor
acknowledges that no other Investor has acted as agent for such Investor in
connection with making its investment hereunder and that no Investor will be
acting as agent of such Investor in connection with monitoring its investment
in the Securities or enforcing its rights under the Transaction Documents.  Each Investor shall be entitled to
independently protect and enforce its rights, including without limitation the
rights arising out of this Agreement or out of the other Transaction Documents,
and it shall not be necessary for any other Investor to be joined as an
additional party in any proceeding for such purpose.  The Company acknowledges that each of the
Investors has been provided with the same Transaction Documents for the purpose
of closing a transaction with multiple Investors and not because it was
required or requested to do so by any Investor. 
The
Company’s obligations to each Investor under this Agreement are identical to
its obligations to each other Investor other than such differences resulting
solely from the number of Securities purchased by each Investor, but regardless
of whether such obligations are memorialized herein or in another agreement
between the Company and an Investor.

Section 6.18           Limitation
of Liability.  Notwithstanding
anything herein to the contrary, the Company acknowledges and agrees that the
liability of an Investor arising directly or indirectly, under any Transaction
Document of any and every nature whatsoever shall be satisfied solely out of
the assets of such Investor, and that no trustee, officer, other investment
vehicle or any other Affiliate of such Investor or any investor, shareholder or
holder of shares of beneficial interest of such a Investor shall be personally
liable for any liabilities of such Investor.

[Remainder of Page
Intentionally Left Blank]

 24
 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first
indicated above.

	
  

  	
  CRDENTIA CORP.

  
	
   

  	
   

  
	
   

  	
   

  
	
  

  	
  By:

  	
   

  	
   

  
	
  

  	
   

  	
  Name: James D.
  Durham

  	
   

  
	
  

  	
   

  	
  Title: Chief
  Executive Officer

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  

 

[Signature Pages for
Investors Follows]

 25
 

IN
WITNESS WHEREOF, the parties hereto have caused this
Securities Purchase Agreement to be duly executed by their respective
authorized signatories as of the date first indicated above.

	
  

  	
  NAME OF INVESTOR

  
	
   

  	
   

  
	
   

  	
   

  
	
  

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  Investment
  Amount: $

  	
   

  	
   

  
	
  

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
  

  	
  Tax ID No.:

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  

  	
  ADDRESS FOR NOTICE

  
	
   

  	
   

  
	
   

  	
   

  
	
  

  	
  c/o: 

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Street:

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  City/State/Zip: 

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Attention: 

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Tel:

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Fax:

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  DELIVERY INSTRUCTIONS

  	
   

  
	
   

  	
  (if
  different from above)

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  

  	
  c/o: 

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Street:

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  City/State/Zip: 

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Attention: 

  	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Tel:

  	
   

  	
   

  
											

 

 26
 

Schedule 3.1(b)

The Company and each Subsidiary are not currently in
good standing in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary.  Specifically, the Company is not in good standing
in Arizona.

Schedule 3.1(l)

The Company has applied for an Arizona license and is
waiting for a state survey to be completed.

Schedule 3.1(aa)

The Company and each of its Subsidiaries have not made
or filed all foreign, federal and state income and all other tax returns,
reports and declarations required by any jurisdiction to which it is subject.

 27

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}]]